Clinical analysis of 86 cases of acute fatty liver of pregnancy.
10.3760/cma.j.cn112141-20230814-00047
- Author:
Cong Li LIU
1
;
Dun Jin CHEN
1
;
Chu Yi CHEN
2
;
Xiu Hua ZHOU
2
;
Yuan JIANG
2
;
Jing Yu LIU
2
;
Yue E CHEN
2
;
Cheng Ran HU
2
;
Jin Ju DONG
1
;
Ping LI
3
;
Min WEN
4
;
Yan Hui LI
5
;
Hui Li ZHANG
1
Author Information
1. Department of Obstetrics and Gynecology, the Third Affiliated Hospital of Guangzhou Medical University, Guangdong Provincial Key Laboratory of Major Obstetric Diseases, Guangzhou 510150, China.
2. Department of Obstetrics and Gynecology, the Third Clinical College of Guangzhou Medical University, Guangzhou 511436, China.
3. Department of Obstetrics and Gynecology, the Maternal and Child Health Hospital of Hunan Province, Changsha 410028, China.
4. Department of Obstetrics and Gynecology, the Fourth People's Hospital of Guiyang, Guiyang 550007, China.
5. Department of Obstetrics and Gynecology, the First People's Hospital of Yulin, Yulin 537000, China.
- Publication Type:Journal Article
- MeSH:
Pregnancy;
Infant, Newborn;
Female;
Humans;
Adult;
Retrospective Studies;
Premature Birth/epidemiology*;
Pregnancy Complications/diagnosis*;
Fatty Liver/diagnosis*;
Fetal Death;
Stillbirth
- From:
Chinese Journal of Obstetrics and Gynecology
2023;58(12):896-902
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinical characteristics and maternal and fetal prognosis of pregnant women with acute fatty liver of pregnancy (AFLP). Methods: The clinical data of 86 AFLP pregnant women admitted to the Third Affiliated Hospital of Guangzhou Medical University from September 2017 to August 2022 were collected, and their general data, clinical characteristics, laboratory tests and maternal and fetal outcomes were retrospectively analyzed. Results: (1) General information: the age of the 86 pregnant women with AFLP was (30.8±5.4) years, and the body mass index was (21.0±2.5) kg/m2. There were 50 primiparas (58.1%, 50/86) and 36 multiparas (41.9%, 36/86). There were 64 singleton pregnancies (74.4%, 64/86) and 22 twin pregnancies (25.6%, 22/86). (2) Clinical characteristics: the main complaints of AFLP pregnant women were gastrointestinal symptoms, including epigastric pain (68.6%, 59/86), nausea (47.7%, 41/86), anorexia (46.5%, 40/86), vomiting (39.5%, 34/86). The main non-gastrointestinal symptoms were jaundice of skin and/or scleral (54.7%, 47/86), edema (38.4%, 33/86), fatigue (19.8%, 17/86), bleeding tendency (16.3%, 14/86), polydipsia or polyuria (14.0%, 12/86), skin itching (8.1%, 7/86), and 17.4% (15/86) AFLP pregnant women had no obvious symptoms. (3) Laboratory tests: the incidence of liver and kidney dysfunction and abnormal coagulation function in AFLP pregnant women was high, and the levels of blood ammonia, lactate dehydrogenase and lactic acid were increased, and the levels of hemoglobin, platelet and albumin decreased. However, only 24 cases (27.9%, 24/86) of AFLP pregnant women showed fatty liver by imageology examination. (4) Pregnancy outcomes: ① AFLP pregnant women had a high incidence of pregnancy complications, mainly including renal insufficiency (95.3%, 82/86), preterm birth (46.5%, 40/86), hypertensive disorders in pregnancy (30.2%, 26/86), gestational diabetes mellitus (36.0%, 31/86), fetal distress (24.4%, 21/86), pulmonary infection (23.3%, 20/86), disseminated intravascular coagulation (16.3%, 14/86), multiple organ dysfunction syndrome (16.3%, 14/86), hepatic encephalopathy (9.3%, 8/86), and intrauterine fetal death (2.3%, 2/86). ② Treatment and outcome of AFLP pregnant women: the intensive care unit transfer rate of AFLP pregnant women was 66.3% (57/86). 82 cases were improved and discharged after treatment, 2 cases were transferred to other hospitals for follow-up treatment, and 2 cases (2.3%, 2/86) died. ③ Neonatal outcomes: except for 2 cases of intrauterine death, a total of 106 neonates were delivered, including 39 cases (36.8%, 39/106) of neonatal asphyxia, 63 cases (59.4%, 63/106) of neonatal intensive care unit admission, and 3 cases (2.8%, 3/106) of neonatal death. Conclusions: AFLP is a severe obstetric complication, which is harmful to mother and fetus. In the process of clinical diagnosis and treatment, attention should be paid to the clinical manifestations and laboratory tests of pregnant women, early diagnosis and active treatment, so as to improve maternal and fetal outcomes.
